<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2023-9-3-0-2</article-id><article-id pub-id-type="publisher-id">3162</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Outcomes of ROHs (runs of homozygosity)/LCSHs (long contiguous stretches of homozygosity) spanning the imprinted loci of chromosomes 7, 11 and 15 among children with neurodevelopmental disorders&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Outcomes of ROHs (runs of homozygosity)/LCSHs (long contiguous stretches of homozygosity) spanning the imprinted loci of chromosomes 7, 11 and 15 among children with neurodevelopmental disorders&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kurinnaia</surname><given-names>Oksana S.</given-names></name><name xml:lang="en"><surname>Kurinnaia</surname><given-names>Oksana S.</given-names></name></name-alternatives><email>kurinnaiaos@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Vasin</surname><given-names>Kirill S.</given-names></name><name xml:lang="en"><surname>Vasin</surname><given-names>Kirill S.</given-names></name></name-alternatives><email>vasin-ks@rambler.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Zelenova</surname><given-names>Maria A.</given-names></name><name xml:lang="en"><surname>Zelenova</surname><given-names>Maria A.</given-names></name></name-alternatives><email>maria_zelenova@yahoo.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Yurov</surname><given-names>Yuri B.</given-names></name><name xml:lang="en"><surname>Yurov</surname><given-names>Yuri B.</given-names></name></name-alternatives><email>ivan.iourov@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Voinova</surname><given-names>Victoria Y.</given-names></name><name xml:lang="en"><surname>Voinova</surname><given-names>Victoria Y.</given-names></name></name-alternatives><email>vivoinova@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Vorsanova</surname><given-names>Svetlana G.</given-names></name><name xml:lang="en"><surname>Vorsanova</surname><given-names>Svetlana G.</given-names></name></name-alternatives><email>svorsanova@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Iourov</surname><given-names>Ivan Y.</given-names></name><name xml:lang="en"><surname>Iourov</surname><given-names>Ivan Y.</given-names></name></name-alternatives><email>ivan.iourov@gmail.com</email></contrib></contrib-group><pub-date pub-type="epub"><year>2023</year></pub-date><volume>9</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2023/3/НР_БМИ_2023_312-321.pdf" /><abstract xml:lang="ru"><p>Background:&amp;nbsp;Runs of homozygosity or long contiguous stretches of homozygosity (ROHs/LCSHs) are common in the human genome. ROHs/LCSHs spanning the imprinted loci have been previously associated with neurodevelopmental disorders. However, the outcomes of these epigenomic variations remain enigmatic. Accordingly, there is a need to evaluate the ROHs/LCSHs outcomes covering the imprinted loci. The aim of the study:&amp;nbsp;To describe the outcomes of ROHs/LCSHs spanning the imprinted loci of chromosomes 7, 11 and 15 among children with neurodevelopmental disorders. Materials and methods:&amp;nbsp;Using molecular karyotyping by high-resolution SNP array, we obtained data on ROHs/LCSHs from 772 children with neurodevelopmental disorders and congenital malformations. ROHs/LCSHs spanning the imprinted loci of chromosomes 7, 11 and 15 were additionally analyzed by original bioinformatic approaches to uncover the pathogenic value. Results:&amp;nbsp;ROHs/LCSHs spanning the imprinted loci of chromosomes 7, 11 and 15 were detected in 67 (8.7%) individuals. Bioinformatic analyses demonstrated that ROHs/LCSHs affecting imprinted loci of chromosome 7 are not associated with clearly recognizable outcomes. Alternatively, ROHs/LCSHs affecting imprinted loci of chromosome 11 (11p15.5p15.4; Beckwith-Wiedemann syndrome) and chromosome 15 (15q11.2; Prader-Willi/Angelman syndromes) were associated with distinct outcomes as shown by bioinformatics approaches. Prader-Willi/Angelman syndrome loci were affected in 18 cases (2.3%), whereas Beckwith-Wiedemann syndrome loci were affected in 10 cases (1.3%). Conclusion:&amp;nbsp;Analysis of the outcomes of ROHs/LCSHs spanning the imprinted loci of chromosomes 7, 11 and 15 has demonstrated that the epigenomic changes affecting 11p15.5p15.4, and 15q11.2 (28 cases; 3.6%) are associated with atypical forms of Beckwith-Wiedemann and Prader-Willi/Angelman syndromes, respectively. The outcomesof ROHs/LCSHs in chromosome 7 have not been found convincing for a definitive conclusion about the phenotypic effects. Molecular karyotyping by SNP array is a valuable diagnostic technique offering opportunities for detecting these common but underestimated epigenetic causes for neurodevelopmental disorders and congenital malformations.</p></abstract><trans-abstract xml:lang="en"><p>Background:&amp;nbsp;Runs of homozygosity or long contiguous stretches of homozygosity (ROHs/LCSHs) are common in the human genome. ROHs/LCSHs spanning the imprinted loci have been previously associated with neurodevelopmental disorders. However, the outcomes of these epigenomic variations remain enigmatic. Accordingly, there is a need to evaluate the ROHs/LCSHs outcomes covering the imprinted loci. The aim of the study:&amp;nbsp;To describe the outcomes of ROHs/LCSHs spanning the imprinted loci of chromosomes 7, 11 and 15 among children with neurodevelopmental disorders. Materials and methods:&amp;nbsp;Using molecular karyotyping by high-resolution SNP array, we obtained data on ROHs/LCSHs from 772 children with neurodevelopmental disorders and congenital malformations. ROHs/LCSHs spanning the imprinted loci of chromosomes 7, 11 and 15 were additionally analyzed by original bioinformatic approaches to uncover the pathogenic value. Results:&amp;nbsp;ROHs/LCSHs spanning the imprinted loci of chromosomes 7, 11 and 15 were detected in 67 (8.7%) individuals. Bioinformatic analyses demonstrated that ROHs/LCSHs affecting imprinted loci of chromosome 7 are not associated with clearly recognizable outcomes. Alternatively, ROHs/LCSHs affecting imprinted loci of chromosome 11 (11p15.5p15.4; Beckwith-Wiedemann syndrome) and chromosome 15 (15q11.2; Prader-Willi/Angelman syndromes) were associated with distinct outcomes as shown by bioinformatics approaches. Prader-Willi/Angelman syndrome loci were affected in 18 cases (2.3%), whereas Beckwith-Wiedemann syndrome loci were affected in 10 cases (1.3%). Conclusion:&amp;nbsp;Analysis of the outcomes of ROHs/LCSHs spanning the imprinted loci of chromosomes 7, 11 and 15 has demonstrated that the epigenomic changes affecting 11p15.5p15.4, and 15q11.2 (28 cases; 3.6%) are associated with atypical forms of Beckwith-Wiedemann and Prader-Willi/Angelman syndromes, respectively. The outcomesof ROHs/LCSHs in chromosome 7 have not been found convincing for a definitive conclusion about the phenotypic effects. Molecular karyotyping by SNP array is a valuable diagnostic technique offering opportunities for detecting these common but underestimated epigenetic causes for neurodevelopmental disorders and congenital malformations.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>chromosome</kwd><kwd>runs of homozygosity</kwd><kwd>long contiguous stretches of homozygosity</kwd><kwd>neurodevelopmental disorders</kwd><kwd>SNP array</kwd><kwd>bioinformatics</kwd><kwd>cytogenomics</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chromosome</kwd><kwd>runs of homozygosity</kwd><kwd>long contiguous stretches of homozygosity</kwd><kwd>neurodevelopmental disorders</kwd><kwd>SNP array</kwd><kwd>bioinformatics</kwd><kwd>cytogenomics</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Ceballos FC, Joshi PK, Clark DW, et al. Runs of homozygosity: windows into population history and trait architecture. Nature Reviews Genetics. 2018;19(4):220-234. DOI: https://doi.org/10.1038/nrg.2017.109</mixed-citation></ref><ref id="B2"><mixed-citation>Szpiech ZA, Mak ACY, White MJ, et al. Ancestry-dependent enrichment of deleterious homozygotes in runs of homozygosity. American Journal of Human Genetics. 2019;105(4):747-762. DOI: https://10.1016/j.ajhg.2019.08.011</mixed-citation></ref><ref id="B3"><mixed-citation>Iourov IY, Vorsanova SG, Korostelev SA, et al. Long contiguous stretches of homozygosity spanning shortly the imprinted loci are associated with intellectual disability, autism and/or epilepsy. Molecular Cytogenetics. 2015;8:77. DOI: https://doi.org/10.1186/s13039-015-0199-3</mixed-citation></ref><ref id="B4"><mixed-citation>Iourov IY, Vorsanova SG, Zelenova MA, et al. Epigenomic variations manifesting as a loss of heterozygosity affecting imprinted genes represent a molecular mechanism of autism spectrum disorders and intellectual disability in children. Journal of Neurology i Psychiatry imeni S.S. Korsakova. 2019;119(5):91-97. Russian. DOI: https://doi.org/10.17116/jnevro201911905191</mixed-citation></ref><ref id="B5"><mixed-citation>Chaves TF, Oliveira LF, Ocampos M, et al. Long contiguous stretches of homozygosity detected by chromosomal microarrays (CMA) in patients with neurodevelopmental disorders in the South of Brazil. BMC Medical Genomics. 2019;12(1):50. DOI: https://10.1186/s12920-019-0496-5</mixed-citation></ref><ref id="B6"><mixed-citation>Mishra A, Prabha PK, Singla R, et al. Epigenetic interface of autism spectrum disorders (ASDs): implications of chromosome 15q11-q13 segment. ACS Chemical Neuroscience. 2022;13(12):1684-1696. DOI: https://10.1021/acschemneuro.2c00060</mixed-citation></ref><ref id="B7"><mixed-citation>Iourov IY, Vorsanova SG, Yurov YB. Runs of homozygosity and epigenetic deregulation of genomic imprinting. OBM Genetics 2018;2(3):028. DOI: https://doi.org/10.21926/obm.genet.1803028</mixed-citation></ref><ref id="B8"><mixed-citation>Iourov IY, Vorsanova SG, Yurov YB. Pathway-based classification of genetic diseases. Molecular Cytogenetics. 2019;12:4. DOI: https://doi.org/10.1186/s13039-019-0418-4</mixed-citation></ref><ref id="B9"><mixed-citation>Ghulam A, Lei X, Guo M, Bian C. Comprehensive analysis of features and annotations of pathway databases. Current Bioinformatics. 2020;15(8):803-820. DOI: https://doi.org/10.2174/1574893615999200413123352</mixed-citation></ref><ref id="B10"><mixed-citation>Jiang X-F, Xiong L, Bai L, et al. Structure and dynamics of human complication-disease network. Chaos, Solitons and Fractals. 2022;164:112633. DOI: https://doi.org/10.1016/j.chaos.2022.112633</mixed-citation></ref><ref id="B11"><mixed-citation>Heng HH, Horne SD, Chaudhry S, et al. A postgenomic perspective on molecular cytogenetics. Current Genomics. 2018;19(3):227-239. DOI: https://doi.org/10.2174/1389202918666170717145716</mixed-citation></ref><ref id="B12"><mixed-citation>Iourov IY, Vorsanova SG, Yurov YB. The variome concept: focus on CNVariome. Molecular Cytogenetics. 2019;12:52. DOI: https://doi.org/10.1186/s13039-019-0467-8</mixed-citation></ref><ref id="B13"><mixed-citation>Monk D, Mackay DJG, Eggermann T, et al. Genomic imprinting disorders: lessons on how genome, epigenome and environment interact. Nature Reviews in Genetics. 2019;20(4):235-248. DOI: https://doi.org/10.1038/s41576-018-0092-0</mixed-citation></ref><ref id="B14"><mixed-citation>Butler MG. Imprinting disorders in humans: a review. Current Opinion in Pediatrics. 2020;32(6):719-729. DOI: https://doi.org/10.1097/MOP.0000000000000965</mixed-citation></ref><ref id="B15"><mixed-citation>Eggermann T, Davies JH, Tauber M, et al. Growth restriction and genomic imprinting-overlapping phenotypes support the concept of an imprinting network. Genes. 2021;12(4):585. DOI: https://doi.org/10.3390/genes12040585</mixed-citation></ref><ref id="B16"><mixed-citation>Isles AR. The contribution of imprinted genes to neurodevelopmental and neuropsychiatric disorders. Translational Psychiatry. 2022;12(1):210. DOI: https://doi.org/10.1038/s41398-022-01972-4</mixed-citation></ref><ref id="B17"><mixed-citation>Aypar U, Hoppman NL, Thorland EC, Dawson DB. Patients with mosaic methylation patterns of the Prader-Willi/Angelman Syndrome critical region exhibit AS-like phenotypes with some PWS features. Molecular Cytogenetics. 2016;9:26. DOI: https://doi.org/10.1186/s13039-016-0233-0</mixed-citation></ref><ref id="B18"><mixed-citation>Nakabayashi K, Fernandez BA, Teshima I, et al. Molecular genetic studies of human chromosome 7 in Russell-Silver syndrome. Genomics. 2002;79(2):186-96. DOI: https://doi.org/10.1006/geno.2002.6695</mixed-citation></ref><ref id="B19"><mixed-citation>Sazhenova EA, Lebedev IN. Epigenetic mosaicism in genomic imprinting disorders. Russian Journal of Genetics. 2019;55(10):1196-1207. DOI: https://doi.org/10.1134/S1022795419100119</mixed-citation></ref><ref id="B20"><mixed-citation>Mendiola AJP, LaSalle JM. Epigenetics in Prader-Willi syndrome. Frontiers in Genetics. 2021;12:624581. DOI: https://doi.org/10.3389/fgene.2021.624581</mixed-citation></ref><ref id="B21"><mixed-citation>Iourov IY, Vorsanova SG, Yurov YB, et al. The cytogenomic &amp;quot;theory of everything&amp;quot;: chromohelkosis may underlie chromosomal instability and mosaicism in disease and aging. International Journal of Molecular Sciences. 2020;21(21):8328. DOI: https://doi.org/10.3390/ijms21218328</mixed-citation></ref><ref id="B22"><mixed-citation>Vorsanova SG, Demidova IA, Kolotii AD, et al. Klinefelter syndrome mosaicism in boys with neurodevelopmental disorders: a cohort study and an extension of the hypothesis. Molecular Cytogenetics. 2022;15(1):8. DOI: https://doi.org/10.1186/s13039-022-00588-z</mixed-citation></ref><ref id="B23"><mixed-citation>Romdhane L, Mezzi N, Dallali H, et al. A map of copy number variations in the Tunisian population: a valuable tool for medical genomics in North Africa. NPJ Genomic Medicine. 2021;6(1):3. DOI: https://doi.org/10.1038/s41525-020-00166-5</mixed-citation></ref><ref id="B24"><mixed-citation>Iourov IY, Vorsanova SG, Yurov YB. In silico molecular cytogenetics: a bioinformatics approach to prioritization of candidate genes and copy number variations for basic and clinical genome research. Molecular Cytogenetics. 2014;7(1):98. DOI: https://doi.org/10.1186/s13039-014-0098-z</mixed-citation></ref><ref id="B25"><mixed-citation>Yurov YB, Vorsanova SG, Iourov IY. Network-based classification of molecular cytogenetic data. Current Bioinformatics. 2017;12:27-33. DOI: https://doi.org/10.2174/1574893611666160606165119</mixed-citation></ref><ref id="B26"><mixed-citation>Fan YS, Ouyang X, Peng J, et al. Frequent detection of parental consanguinity in children with developmental disorders by a combined CGH and SNP microarray. Molecular Cytogenetics. 2013;6(1):38. DOI: https://doi.org/10.1186/1755-8166-6-38</mixed-citation></ref><ref id="B27"><mixed-citation>Del Gaudio D, Shinawi M, Astbury C, et al. ACMG Laboratory Quality Assurance Committee. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 2020;22(7):1133-1141. DOI: https://doi.org/10.1038/s41436-020-0782-9</mixed-citation></ref><ref id="B28"><mixed-citation>Vorsanova SG, Yurov YB, Soloviev IV, et al. Molecular cytogenetic diagnosis and somatic genome variations. Current Genomics. 2010;11(6):440-446. DOI: https://doi.org/10.2174/138920210793176010</mixed-citation></ref><ref id="B29"><mixed-citation>Pellikaan K, van Woerden GM, Kleinendorst L, et al. The diagnostic journey of a patient with Prader-Willi-Like syndrome and a unique homozygous SNURF-SNRPN variant; bio-molecular analysis and review of the literature. Genes. 2021;12(6):875. DOI: https://doi.org/10.3390/genes12060875</mixed-citation></ref><ref id="B30"><mixed-citation>Iourov IY, Vorsanova SG, Kurinnaaya OS, et al. The use of molecular cytogenetic and cytogenetic techniques for the diagnosis of Prader-Willi and Angelman syndrome. Journal of Neurology i Psychiatry imeni S.S. Korsakova. 2014;114(1):49-53. Russian.</mixed-citation></ref><ref id="B31"><mixed-citation>Fontana L, Tabano S, Maitz S, et al. Clinical and molecular diagnosis of Beckwith-Wiedemann syndrome with single- or multi-locus imprinting disturbance. International Journal of Molecular Sciences. 2021;22(7):3445. DOI: https://doi.org/10.3390/ijms22073445</mixed-citation></ref><ref id="B32"><mixed-citation>Andergassen D, Smith ZD, Kretzmer H, et al. Diverse epigenetic mechanisms maintain parental imprints within the embryonic and extraembryonic lineages. Developmental Cell. 2021;56(21):2995-3005.e4. DOI: https://doi.org/10.1016/j.devcel.2021.10.010</mixed-citation></ref><ref id="B33"><mixed-citation>Jima DD, Skaar DA, Planchart A, et al. Genomic map of candidate human imprint control regions: the imprintome. Epigenetics. 2022;17(13):1920-1943. DOI: https://doi.org/10.1080/15592294.2022.2091815</mixed-citation></ref><ref id="B34"><mixed-citation>Liehr T. Uniparental disomy is a chromosomic disorder in the first place. Molecular Cytogenetics. 2022;15(1):5. DOI: https://doi.org/10.1186/s13039-022-00585-2</mixed-citation></ref><ref id="B35"><mixed-citation>Iourov IY, Gerasimov AP, Zelenova MA, et al. Cytogenomic epileptology. Molecular Cytogenetics. 2023;16(1):1. DOI: https://doi.org/10.1186/s13039-022-00634-w</mixed-citation></ref><ref id="B36"><mixed-citation>Heng E, Thanedar S, Heng HH. Challenges and opportunities for clinical cytogenetics in the 21st century. Genes. 2023;14(2):493. DOI: https://doi.org/10.3390/genes14020493</mixed-citation></ref><ref id="B37"><mixed-citation>Iourov IY, Vorsanova SG, Yurov YB. Systems cytogenomics: are we ready yet? Current Genomics. 2021;22(2):75-78. DOI: https://doi.org/10.2174/1389202922666210219112419</mixed-citation></ref></ref-list></back></article>